Global Small Molecule Drug CDMO Market Research Report 2026(Status and Outlook)

May 2026 | 164 pages | ID: G2088F57DD73EN
Bosson Research

Abstracts

A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Small Molecule Drug CDMO market size was estimated at USD 31050.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.90% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Small Molecule Drug CDMO market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Small Molecule Drug CDMO market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Small Molecule Drug CDMO market.

Global Small Molecule Drug CDMO Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Lonza
• Catalent
• Thermo Fisher Scientific
• Samsung Biologics
• Fareva
• WuXi AppTech
• WuXi Biologics
• Siegfried
• FUJIFILM Diosynth Biotechnologies
• Asymchem
• Pfizer CentreOne
• Delpharm
• Recipharm
• AGC Pharma Chemicals
• Boehringer Ingelheim
• Vetter
• Curia
• Aenova
• Porton

Market Segmentation (by Type)

• FDF CDMO
• Packaging CDMO
• Clinical CDMO

Market Segmentation (by Application)

• Pharmaceutical Company
• Biotechnology Company
• Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Small Molecule Drug CDMO Market

Overview of the regional outlook of the Small Molecule Drug CDMO Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Small Molecule Drug CDMO Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Small Molecule Drug CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Small Molecule Drug CDMO
1.2 Key Market Segments
  1.2.1 Small Molecule Drug CDMO Segment by Type
  1.2.2 Small Molecule Drug CDMO Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 SMALL MOLECULE DRUG CDMO MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Small Molecule Drug CDMO Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Small Molecule Drug CDMO Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 SMALL MOLECULE DRUG CDMO MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Small Molecule Drug CDMO Product Life Cycle
3.3 Global Small Molecule Drug CDMO Sales by Manufacturers (2020-2025)
3.4 Global Small Molecule Drug CDMO Revenue Market Share by Manufacturers (2020-2025)
3.5 Small Molecule Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Small Molecule Drug CDMO Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Small Molecule Drug CDMO Market Competitive Situation and Trends
  3.8.1 Small Molecule Drug CDMO Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Small Molecule Drug CDMO Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 SMALL MOLECULE DRUG CDMO INDUSTRY CHAIN ANALYSIS

4.1 Small Molecule Drug CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF SMALL MOLECULE DRUG CDMO MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Small Molecule Drug CDMO Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Small Molecule Drug CDMO Market
5.7 ESG Ratings of Leading Companies

6 SMALL MOLECULE DRUG CDMO MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Small Molecule Drug CDMO Sales Market Share by Type (2020-2025)
6.3 Global Small Molecule Drug CDMO Market Size by Type (2020-2025)
6.4 Global Small Molecule Drug CDMO Price by Type (2020-2025)

7 SMALL MOLECULE DRUG CDMO MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Small Molecule Drug CDMO Market Sales by Application (2020-2025)
7.3 Global Small Molecule Drug CDMO Market Size (M USD) by Application (2020-2025)
7.4 Global Small Molecule Drug CDMO Sales Growth Rate by Application (2020-2025)

8 SMALL MOLECULE DRUG CDMO MARKET SALES BY REGION

8.1 Global Small Molecule Drug CDMO Sales by Region
  8.1.1 Global Small Molecule Drug CDMO Sales by Region
  8.1.2 Global Small Molecule Drug CDMO Sales Market Share by Region
8.2 Global Small Molecule Drug CDMO Market Size by Region
  8.2.1 Global Small Molecule Drug CDMO Market Size by Region
  8.2.2 Global Small Molecule Drug CDMO Market Size by Region
8.3 North America
  8.3.1 North America Small Molecule Drug CDMO Sales by Country
  8.3.2 North America Small Molecule Drug CDMO Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Small Molecule Drug CDMO Sales by Country
  8.4.2 Europe Small Molecule Drug CDMO Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Small Molecule Drug CDMO Sales by Region
  8.5.2 Asia Pacific Small Molecule Drug CDMO Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Small Molecule Drug CDMO Sales by Country
  8.6.2 South America Small Molecule Drug CDMO Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Small Molecule Drug CDMO Sales by Region
  8.7.2 Middle East and Africa Small Molecule Drug CDMO Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 SMALL MOLECULE DRUG CDMO MARKET PRODUCTION BY REGION

9.1 Global Production of Small Molecule Drug CDMO by Region(2020-2025)
9.2 Global Small Molecule Drug CDMO Revenue Market Share by Region (2020-2025)
9.3 Global Small Molecule Drug CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Small Molecule Drug CDMO Production
  9.4.1 North America Small Molecule Drug CDMO Production Growth Rate (2020-2025)
  9.4.2 North America Small Molecule Drug CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Small Molecule Drug CDMO Production
  9.5.1 Europe Small Molecule Drug CDMO Production Growth Rate (2020-2025)
  9.5.2 Europe Small Molecule Drug CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Small Molecule Drug CDMO Production (2020-2025)
  9.6.1 Japan Small Molecule Drug CDMO Production Growth Rate (2020-2025)
  9.6.2 Japan Small Molecule Drug CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Small Molecule Drug CDMO Production (2020-2025)
  9.7.1 China Small Molecule Drug CDMO Production Growth Rate (2020-2025)
  9.7.2 China Small Molecule Drug CDMO Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Lonza
  10.1.1 Lonza Basic Information
  10.1.2 Lonza Small Molecule Drug CDMO Product Overview
  10.1.3 Lonza Small Molecule Drug CDMO Product Market Performance
  10.1.4 Lonza Business Overview
  10.1.5 Lonza SWOT Analysis
  10.1.6 Lonza Recent Developments
10.2 Catalent
  10.2.1 Catalent Basic Information
  10.2.2 Catalent Small Molecule Drug CDMO Product Overview
  10.2.3 Catalent Small Molecule Drug CDMO Product Market Performance
  10.2.4 Catalent Business Overview
  10.2.5 Catalent SWOT Analysis
  10.2.6 Catalent Recent Developments
10.3 Thermo Fisher Scientific
  10.3.1 Thermo Fisher Scientific Basic Information
  10.3.2 Thermo Fisher Scientific Small Molecule Drug CDMO Product Overview
  10.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Product Market Performance
  10.3.4 Thermo Fisher Scientific Business Overview
  10.3.5 Thermo Fisher Scientific SWOT Analysis
  10.3.6 Thermo Fisher Scientific Recent Developments
10.4 Samsung Biologics
  10.4.1 Samsung Biologics Basic Information
  10.4.2 Samsung Biologics Small Molecule Drug CDMO Product Overview
  10.4.3 Samsung Biologics Small Molecule Drug CDMO Product Market Performance
  10.4.4 Samsung Biologics Business Overview
  10.4.5 Samsung Biologics Recent Developments
10.5 Fareva
  10.5.1 Fareva Basic Information
  10.5.2 Fareva Small Molecule Drug CDMO Product Overview
  10.5.3 Fareva Small Molecule Drug CDMO Product Market Performance
  10.5.4 Fareva Business Overview
  10.5.5 Fareva Recent Developments
10.6 WuXi AppTech
  10.6.1 WuXi AppTech Basic Information
  10.6.2 WuXi AppTech Small Molecule Drug CDMO Product Overview
  10.6.3 WuXi AppTech Small Molecule Drug CDMO Product Market Performance
  10.6.4 WuXi AppTech Business Overview
  10.6.5 WuXi AppTech Recent Developments
10.7 WuXi Biologics
  10.7.1 WuXi Biologics Basic Information
  10.7.2 WuXi Biologics Small Molecule Drug CDMO Product Overview
  10.7.3 WuXi Biologics Small Molecule Drug CDMO Product Market Performance
  10.7.4 WuXi Biologics Business Overview
  10.7.5 WuXi Biologics Recent Developments
10.8 Siegfried
  10.8.1 Siegfried Basic Information
  10.8.2 Siegfried Small Molecule Drug CDMO Product Overview
  10.8.3 Siegfried Small Molecule Drug CDMO Product Market Performance
  10.8.4 Siegfried Business Overview
  10.8.5 Siegfried Recent Developments
10.9 FUJIFILM Diosynth Biotechnologies
  10.9.1 FUJIFILM Diosynth Biotechnologies Basic Information
  10.9.2 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Overview
  10.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Market Performance
  10.9.4 FUJIFILM Diosynth Biotechnologies Business Overview
  10.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
10.10 Asymchem
  10.10.1 Asymchem Basic Information
  10.10.2 Asymchem Small Molecule Drug CDMO Product Overview
  10.10.3 Asymchem Small Molecule Drug CDMO Product Market Performance
  10.10.4 Asymchem Business Overview
  10.10.5 Asymchem Recent Developments
10.11 Pfizer CentreOne
  10.11.1 Pfizer CentreOne Basic Information
  10.11.2 Pfizer CentreOne Small Molecule Drug CDMO Product Overview
  10.11.3 Pfizer CentreOne Small Molecule Drug CDMO Product Market Performance
  10.11.4 Pfizer CentreOne Business Overview
  10.11.5 Pfizer CentreOne Recent Developments
10.12 Delpharm
  10.12.1 Delpharm Basic Information
  10.12.2 Delpharm Small Molecule Drug CDMO Product Overview
  10.12.3 Delpharm Small Molecule Drug CDMO Product Market Performance
  10.12.4 Delpharm Business Overview
  10.12.5 Delpharm Recent Developments
10.13 Recipharm
  10.13.1 Recipharm Basic Information
  10.13.2 Recipharm Small Molecule Drug CDMO Product Overview
  10.13.3 Recipharm Small Molecule Drug CDMO Product Market Performance
  10.13.4 Recipharm Business Overview
  10.13.5 Recipharm Recent Developments
10.14 AGC Pharma Chemicals
  10.14.1 AGC Pharma Chemicals Basic Information
  10.14.2 AGC Pharma Chemicals Small Molecule Drug CDMO Product Overview
  10.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Product Market Performance
  10.14.4 AGC Pharma Chemicals Business Overview
  10.14.5 AGC Pharma Chemicals Recent Developments
10.15 Boehringer Ingelheim
  10.15.1 Boehringer Ingelheim Basic Information
  10.15.2 Boehringer Ingelheim Small Molecule Drug CDMO Product Overview
  10.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Product Market Performance
  10.15.4 Boehringer Ingelheim Business Overview
  10.15.5 Boehringer Ingelheim Recent Developments
10.16 Vetter
  10.16.1 Vetter Basic Information
  10.16.2 Vetter Small Molecule Drug CDMO Product Overview
  10.16.3 Vetter Small Molecule Drug CDMO Product Market Performance
  10.16.4 Vetter Business Overview
  10.16.5 Vetter Recent Developments
10.17 Curia
  10.17.1 Curia Basic Information
  10.17.2 Curia Small Molecule Drug CDMO Product Overview
  10.17.3 Curia Small Molecule Drug CDMO Product Market Performance
  10.17.4 Curia Business Overview
  10.17.5 Curia Recent Developments
10.18 Aenova
  10.18.1 Aenova Basic Information
  10.18.2 Aenova Small Molecule Drug CDMO Product Overview
  10.18.3 Aenova Small Molecule Drug CDMO Product Market Performance
  10.18.4 Aenova Business Overview
  10.18.5 Aenova Recent Developments
10.19 Porton
  10.19.1 Porton Basic Information
  10.19.2 Porton Small Molecule Drug CDMO Product Overview
  10.19.3 Porton Small Molecule Drug CDMO Product Market Performance
  10.19.4 Porton Business Overview
  10.19.5 Porton Recent Developments

11 SMALL MOLECULE DRUG CDMO MARKET FORECAST BY REGION

11.1 Global Small Molecule Drug CDMO Market Size Forecast
11.2 Global Small Molecule Drug CDMO Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Small Molecule Drug CDMO Market Size Forecast by Country
  11.2.3 Asia Pacific Small Molecule Drug CDMO Market Size Forecast by Region
  11.2.4 South America Small Molecule Drug CDMO Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Small Molecule Drug CDMO by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Small Molecule Drug CDMO Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Small Molecule Drug CDMO by Type (2026-2035)
  12.1.2 Global Small Molecule Drug CDMO Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Small Molecule Drug CDMO by Type (2026-2035)
12.2 Global Small Molecule Drug CDMO Market Forecast by Application (2026-2035)
  12.2.1 Global Small Molecule Drug CDMO Sales (K Units) Forecast by Application
  12.2.2 Global Small Molecule Drug CDMO Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Small Molecule Drug CDMO Market Size by Type (M USD)
Table 4. Global Small Molecule Drug CDMO Market Size by Application
Table 5. Small Molecule Drug CDMO Market Size Comparison by Region (M USD)
Table 6. Global Small Molecule Drug CDMO Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Small Molecule Drug CDMO Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Small Molecule Drug CDMO Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Small Molecule Drug CDMO Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO as of 2025)
Table 11. Global Market Small Molecule Drug CDMO Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Small Molecule Drug CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Small Molecule Drug CDMO Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Small Molecule Drug CDMO Sales by Type (K Units)
Table 27. Global Small Molecule Drug CDMO Market Size by Type (M USD)
Table 28. Global Small Molecule Drug CDMO Sales (K Units) by Type (2020-2025)
Table 29. Global Small Molecule Drug CDMO Sales Market Share by Type (2020-2025)
Table 30. Global Small Molecule Drug CDMO Market Size (M USD) by Type (2020-2025)
Table 31. Global Small Molecule Drug CDMO Market Share by Type (2020-2025)
Table 32. Global Small Molecule Drug CDMO Price (USD/Unit) by Type (2020-2025)
Table 33. Global Small Molecule Drug CDMO Sales (K Units) by Application
Table 34. Global Small Molecule Drug CDMO Market Size by Application
Table 35. Global Small Molecule Drug CDMO Sales by Application (2020-2025) & (K Units)
Table 36. Global Small Molecule Drug CDMO Sales Market Share by Application (2020-2025)
Table 37. Global Small Molecule Drug CDMO Market Size by Application (2020-2025) & (M USD)
Table 38. Global Small Molecule Drug CDMO Market Share by Application (2020-2025)
Table 39. Global Small Molecule Drug CDMO Sales Growth Rate by Application (2020-2025)
Table 40. Global Small Molecule Drug CDMO Sales by Region (2020-2025) & (K Units)
Table 41. Global Small Molecule Drug CDMO Sales Market Share by Region (2020-2025)
Table 42. Global Small Molecule Drug CDMO Market Size by Region (2020-2025) & (M USD)
Table 43. Global Small Molecule Drug CDMO Market Size by Region (2020-2025)
Table 44. North America Small Molecule Drug CDMO Sales by Country (2020-2025) & (K Units)
Table 45. North America Small Molecule Drug CDMO Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Small Molecule Drug CDMO Sales by Country (2020-2025) & (K Units)
Table 47. Europe Small Molecule Drug CDMO Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Small Molecule Drug CDMO Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Small Molecule Drug CDMO Market Size by Region (2020-2025) & (M USD)
Table 50. South America Small Molecule Drug CDMO Sales by Country (2020-2025) & (K Units)
Table 51. South America Small Molecule Drug CDMO Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Small Molecule Drug CDMO Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Small Molecule Drug CDMO Market Size by Region (2020-2025) & (M USD)
Table 54. Global Small Molecule Drug CDMO Production (K Units) by Region(2020-2025)
Table 55. Global Small Molecule Drug CDMO Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Small Molecule Drug CDMO Revenue Market Share by Region (2020-2025)
Table 57. Global Small Molecule Drug CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Small Molecule Drug CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Small Molecule Drug CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Small Molecule Drug CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Small Molecule Drug CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Lonza Basic Information
Table 63. Lonza Small Molecule Drug CDMO Product Overview
Table 64. Lonza Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Lonza Business Overview
Table 66. Lonza SWOT Analysis
Table 67. Lonza Recent Developments
Table 68. Catalent Basic Information
Table 69. Catalent Small Molecule Drug CDMO Product Overview
Table 70. Catalent Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Catalent Business Overview
Table 72. Catalent SWOT Analysis
Table 73. Catalent Recent Developments
Table 74. Thermo Fisher Scientific Basic Information
Table 75. Thermo Fisher Scientific Small Molecule Drug CDMO Product Overview
Table 76. Thermo Fisher Scientific Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific SWOT Analysis
Table 79. Thermo Fisher Scientific Recent Developments
Table 80. Samsung Biologics Basic Information
Table 81. Samsung Biologics Small Molecule Drug CDMO Product Overview
Table 82. Samsung Biologics Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Samsung Biologics Business Overview
Table 84. Samsung Biologics Recent Developments
Table 85. Fareva Basic Information
Table 86. Fareva Small Molecule Drug CDMO Product Overview
Table 87. Fareva Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Fareva Business Overview
Table 89. Fareva Recent Developments
Table 90. WuXi AppTech Basic Information
Table 91. WuXi AppTech Small Molecule Drug CDMO Product Overview
Table 92. WuXi AppTech Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. WuXi AppTech Business Overview
Table 94. WuXi AppTech Recent Developments
Table 95. WuXi Biologics Basic Information
Table 96. WuXi Biologics Small Molecule Drug CDMO Product Overview
Table 97. WuXi Biologics Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. WuXi Biologics Business Overview
Table 99. WuXi Biologics Recent Developments
Table 100. Siegfried Basic Information
Table 101. Siegfried Small Molecule Drug CDMO Product Overview
Table 102. Siegfried Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Siegfried Business Overview
Table 104. Siegfried Recent Developments
Table 105. FUJIFILM Diosynth Biotechnologies Basic Information
Table 106. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Overview
Table 107. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. FUJIFILM Diosynth Biotechnologies Business Overview
Table 109. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 110. Asymchem Basic Information
Table 111. Asymchem Small Molecule Drug CDMO Product Overview
Table 112. Asymchem Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Asymchem Business Overview
Table 114. Asymchem Recent Developments
Table 115. Pfizer CentreOne Basic Information
Table 116. Pfizer CentreOne Small Molecule Drug CDMO Product Overview
Table 117. Pfizer CentreOne Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Pfizer CentreOne Business Overview
Table 119. Pfizer CentreOne Recent Developments
Table 120. Delpharm Basic Information
Table 121. Delpharm Small Molecule Drug CDMO Product Overview
Table 122. Delpharm Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Delpharm Business Overview
Table 124. Delpharm Recent Developments
Table 125. Recipharm Basic Information
Table 126. Recipharm Small Molecule Drug CDMO Product Overview
Table 127. Recipharm Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Recipharm Business Overview
Table 129. Recipharm Recent Developments
Table 130. AGC Pharma Chemicals Basic Information
Table 131. AGC Pharma Chemicals Small Molecule Drug CDMO Product Overview
Table 132. AGC Pharma Chemicals Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. AGC Pharma Chemicals Business Overview
Table 134. AGC Pharma Chemicals Recent Developments
Table 135. Boehringer Ingelheim Basic Information
Table 136. Boehringer Ingelheim Small Molecule Drug CDMO Product Overview
Table 137. Boehringer Ingelheim Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Boehringer Ingelheim Business Overview
Table 139. Boehringer Ingelheim Recent Developments
Table 140. Vetter Basic Information
Table 141. Vetter Small Molecule Drug CDMO Product Overview
Table 142. Vetter Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Vetter Business Overview
Table 144. Vetter Recent Developments
Table 145. Curia Basic Information
Table 146. Curia Small Molecule Drug CDMO Product Overview
Table 147. Curia Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Curia Business Overview
Table 149. Curia Recent Developments
Table 150. Aenova Basic Information
Table 151. Aenova Small Molecule Drug CDMO Product Overview
Table 152. Aenova Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Aenova Business Overview
Table 154. Aenova Recent Developments
Table 155. Porton Basic Information
Table 156. Porton Small Molecule Drug CDMO Product Overview
Table 157. Porton Small Molecule Drug CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Porton Business Overview
Table 159. Porton Recent Developments
Table 160. Global Small Molecule Drug CDMO Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global Small Molecule Drug CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Small Molecule Drug CDMO Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America Small Molecule Drug CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Small Molecule Drug CDMO Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe Small Molecule Drug CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Small Molecule Drug CDMO Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific Small Molecule Drug CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Small Molecule Drug CDMO Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America Small Molecule Drug CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Small Molecule Drug CDMO Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Small Molecule Drug CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Small Molecule Drug CDMO Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global Small Molecule Drug CDMO Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Small Molecule Drug CDMO Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global Small Molecule Drug CDMO Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global Small Molecule Drug CDMO Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Small Molecule Drug CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Small Molecule Drug CDMO Market Size (M USD), 2025-2035
Figure 5. Global Small Molecule Drug CDMO Market Size (M USD) (2020-2035)
Figure 6. Global Small Molecule Drug CDMO Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Small Molecule Drug CDMO Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Small Molecule Drug CDMO Product Life Cycle
Figure 13. Small Molecule Drug CDMO Sales Share by Manufacturers in 2025
Figure 14. Global Small Molecule Drug CDMO Revenue Share by Manufacturers in 2025
Figure 15. Small Molecule Drug CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Small Molecule Drug CDMO Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Small Molecule Drug CDMO Revenue in 2025
Figure 18. Industry Chain Map of Small Molecule Drug CDMO
Figure 19. Global Small Molecule Drug CDMO Market PEST Analysis
Figure 20. Global Small Molecule Drug CDMO Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Small Molecule Drug CDMO Market Share by Type
Figure 27. Sales Market Share of Small Molecule Drug CDMO by Type (2020-2025)
Figure 28. Sales Market Share of Small Molecule Drug CDMO by Type in 2025
Figure 29. Market Share of Small Molecule Drug CDMO by Type (2020-2025)
Figure 30. Market Share of Small Molecule Drug CDMO by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Small Molecule Drug CDMO Market Share by Application
Figure 33. Global Small Molecule Drug CDMO Sales Market Share by Application (2020-2025)
Figure 34. Global Small Molecule Drug CDMO Sales Market Share by Application in 2025
Figure 35. Global Small Molecule Drug CDMO Market Share by Application (2020-2025)
Figure 36. Global Small Molecule Drug CDMO Market Share by Application in 2025
Figure 37. Global Small Molecule Drug CDMO Sales Growth Rate by Application (2020-2025)
Figure 38. Global Small Molecule Drug CDMO Sales Market Share by Region (2020-2025)
Figure 39. Global Small Molecule Drug CDMO Market Size by Region (2020-2025)
Figure 40. North America Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Small Molecule Drug CDMO Sales Market Share by Country in 2024
Figure 43. North America Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Small Molecule Drug CDMO Market Size by Country in 2024
Figure 45. U.S. Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Small Molecule Drug CDMO Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Small Molecule Drug CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Small Molecule Drug CDMO Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Small Molecule Drug CDMO Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Small Molecule Drug CDMO Sales Market Share by Country in 2024
Figure 53. Europe Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Small Molecule Drug CDMO Market Size by Country in 2024
Figure 55. Germany Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Small Molecule Drug CDMO Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Small Molecule Drug CDMO Sales Market Share by Region in 2024
Figure 67. Asia Pacific Small Molecule Drug CDMO Market Size by Region in 2024
Figure 68. China Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Small Molecule Drug CDMO Sales and Growth Rate (K Units)
Figure 79. South America Small Molecule Drug CDMO Sales Market Share by Country in 2024
Figure 80. South America Small Molecule Drug CDMO Market Size and Growth Rate (M USD)
Figure 81. South America Small Molecule Drug CDMO Market Size by Country in 2024
Figure 82. Brazil Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Small Molecule Drug CDMO Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Small Molecule Drug CDMO Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Small Molecule Drug CDMO Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Small Molecule Drug CDMO Market Size by Region in 2024
Figure 92. Saudi Arabia Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Small Molecule Drug CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Small Molecule Drug CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Small Molecule Drug CDMO Production Market Share by Region (2020-2025)
Figure 103. North America Small Molecule Drug CDMO Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Small Molecule Drug CDMO Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Small Molecule Drug CDMO Production (K Units) Growth Rate (2020-2025)
Figure 106. China Small Molecule Drug CDMO Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Small Molecule Drug CDMO Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Small Molecule Drug CDMO Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Small Molecule Drug CDMO Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Small Molecule Drug CDMO Market Share Forecast by Type (2026-2035)
Figure 111. Global Small Molecule Drug CDMO Sales Forecast by Application (2026-2035)
Figure 112. Global Small Molecule Drug CDMO Market Share Forecast by Application (2026-2035)